4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
13.76
+0.59 (4.48%)
At close: Sep 14, 2026, 4:00 PM EDT
13.76
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:54 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $760.16 million as of September 14, 2026. Its market cap has increased by 139.01% in one year.
Market Cap
760.16M
Enterprise Value
368.75M
1-Year Change
139.01%
Ranking
Category
Stock Price
$13.76
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $760.16M, an increase of 30.98%. That is a compound annual growth rate of 4.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 760.16M | 77.39% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 761.51M |
| Annexon | 746.94M |
| Monopar Therapeutics | 740.08M |
| Achieve Life Sciences | 726.49M |
| MapLight Therapeutics | 722.48M |
| DBV Technologies | 720.55M |
| Aura Biosciences | 718.16M |
| CytomX Therapeutics | 716.89M |